2009 - Use of antipsychotic drugs was associated with increased risk for hyperglycemia in older patients with diabetes

Ng, Bradley; Lipscombe, L. L.
November 2009
ACP Journal Club;11/17/2009, Vol. 151 Issue 5, p10
Academic Journal
The article presents a study which examines whether the use of antipsychotic drugs increases the risk of hyperglycemia in older patients with diabetes mellitus. The study included 15874 diabetes patients of 66 years. The results show that antipsychotic drugs increased the risk of hyperglycemia in older patients with diabetes. First-time antipsychotic users were especially prone to hyperglycemia.


Related Articles

  • Diabetic ketoacidosis associated with atypical antipsychotic drug, clozapine treatment: Report of a case and review of literature. Pillai, L.; Husainy, S. M. K.; Ramchandani, K. // Indian Journal of Critical Care Medicine;Jul-Sep2006, Vol. 10 Issue 3, p193 

    Atypical antipsychotic drugs are associated with metabolic disturbances like weight gain, type 2 diabetes hyperglycaemia and dyslipedemia, which can result in serious health risk in patients. Diabetic ketoacidosis resulting in serious metabolic acidosis, occurring in a schizophrenic patient on...

  • Stroke risk with typical and atypical antipsychotics.  // Reactions Weekly;9/13/2008, Issue 1219, p1 

    The article discusses research being done on the association between the exposure to antipsychotics and the risk of stroke. It references a study by I. J. Douglas and L. Smeeth, published in the "British Medical Journal" in 2008. The researchers conducted a self-controlled case series to achieve...

  • Possible Link Explored Between Antipsychotics And Several Conditions.  // RN;Jun2004, Vol. 67 Issue 6, p76 

    Explores the possible link between antipsychotics and several conditions. Recommendation for monitoring closely on patients who take antipsychotics for signs that they are developing diabetes, obesity, or high cholesterol; Emergence of the consensus statement made by the American Diabetes...

  • SUPPLEMENTARY INFORMATION: Other recent studies of the diabetogenic potential of atypical antipsychotics.  // Canadian Journal of Psychiatry;Jul2003 Supplement, Vol. 48, p12 

    Focuses on some studies of the diabetogenic potential of atypical antipsychotics. Symptoms exhibited by patients of schizophrenia or schizoaffective disorder; Risks associated with administration of quetiapine in psychotic patients.

  • Antipsychotics increase diabetes risk in patients with schizophrenia.  // Reactions Weekly;11/13/2004, Issue 1027, p3 

    Discusses research being done on the effect of the use of antipsychotics on the risk of diabetes mellitus in patients with schizophrenia. Reference to a study by Joseph Proietto published in the October 2004 issue of "Australian Prescriber" journal; Need to monitor the blood glucose of...

  • The Metabolic Effects of Antipsychotic Medications. Newcomer, John W.; Haupt, Dan W. // Canadian Journal of Psychiatry;Jul2006, Vol. 51 Issue 8, p480 

    Objectives: To review current evidence for the hypothesis that treatment with antipsychotic medications may be associated with increased risks for weight gain, insulin resistance, hyperglycemia, dyslipidemia, and type 2 diabetes mellitus (T2DM) and to examine the relation of adiposity to medical...

  • Psychotropic Drugs and Ocular Side Effects. Sönmez, İpek; Aykan, Ümit // Turkish Journal of Ophthalmology / Turk Oftalmoloji Dergisi;Jul/Aug2013, Vol. 43 Issue 4, p270 

    Nowadays the number of patients using the types of drugs in question here has significantly increased. A study carried out in relation with the long term use of psychotropic drugs shows that the consumption of this group of drugs has substantially increased in terms of variety and quantity. This...

  • Most psychoactive therapies have the potential to cause ocular adverse events.  // Drugs & Therapy Perspectives;Feb2011, Vol. 27 Issue 2, p18 

    Numerous ocular adverse events can arise with medications commonly used for the treatment of psychiatric conditions. Selective serotonin reuptake inhibitors, tricyclic antidepressants, lithium, typical and atypical antipsychotics, carbamazepine, benzodiazepines and topiramate have all been...

  • The effects of second-generation antipsychotics on food intake, resting energy expenditure and physical activity. Cuerda, C; Velasco, C; Merchán-Naranjo, J; García-Peris, P; Arango, C // European Journal of Clinical Nutrition;Feb2014, Vol. 68 Issue 2, p146 

    Second-generation antipsychotics (SGA) are associated with weight gain and metabolic alterations including hyperglycemia, dyslipidemia, hypertension and metabolic syndrome. These metabolic side effects increase cardiovascular risk and are related to medication non-compliance. Patients without...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics